| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/29/2010 | CA2252372C Pathogenic escherichia coli associated protein |
| 06/29/2010 | CA2236700C Immunity against pasteurella haemolytica leukotoxin |
| 06/29/2010 | CA2218364C Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 06/29/2010 | CA2187346C Receptor modulating agents and methods relating thereto |
| 06/29/2010 | CA2168409C G cap-stabilized oligonucleotides |
| 06/24/2010 | WO2010071885A1 Pyrrolotriazines as alk and jak2 inhibitors |
| 06/24/2010 | WO2010071872A2 [2.2.2] bicyclic derivatives and methods of use |
| 06/24/2010 | WO2010071866A2 Combination therapy for arthritis with tranilast |
| 06/24/2010 | WO2010071865A1 Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| 06/24/2010 | WO2010071854A1 Treatment of major adverse cardiac events and acute coronary syndrome using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapies |
| 06/24/2010 | WO2010071853A1 Thiazolopyridine sirtuin modulating compounds |
| 06/24/2010 | WO2010071852A2 Oligonucleotide micelles |
| 06/24/2010 | WO2010071846A2 Compounds for treating neuropsychiatric conditions |
| 06/24/2010 | WO2010071837A1 Pyrazine derivatives useful as inhibitors of atr kinase |
| 06/24/2010 | WO2010071826A2 Methods for treating osteoclast-related disease, compounds and compositions thereof |
| 06/24/2010 | WO2010071822A1 Piperidine and piperazine derivatives and methods of use thereof |
| 06/24/2010 | WO2010071819A1 Bicyclic heterocyclic derivatives and methods of use thereof |
| 06/24/2010 | WO2010071813A1 AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-α |
| 06/24/2010 | WO2010071794A1 New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic |
| 06/24/2010 | WO2010071789A1 Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals |
| 06/24/2010 | WO2010071783A1 Thiazoles as cannabinoid receptor ligands |
| 06/24/2010 | WO2010071741A1 Triazole derivatives for treatment of alzheimer's disease |
| 06/24/2010 | WO2010071587A1 A complex and method for enhancing nuclear delivery |
| 06/24/2010 | WO2010071583A1 Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient |
| 06/24/2010 | WO2010071582A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient |
| 06/24/2010 | WO2010071581A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a b2-adrenoceptor agonist |
| 06/24/2010 | WO2010071575A1 Quaternary piperidine derivatives and uses thereof |
| 06/24/2010 | WO2010071567A1 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives |
| 06/24/2010 | WO2010071320A2 Controlled-release composition for producing sustained-release preparation containing udenafil |
| 06/24/2010 | WO2010071313A2 Granules containing lacidipine, and pharmaceutical compositions comprising same |
| 06/24/2010 | WO2010071232A1 A disintegrating tablet |
| 06/24/2010 | WO2010071230A1 Photodynamic therapeutic agent showing accumulation of cell-specific functions |
| 06/24/2010 | WO2010071219A1 16-ketoaspergillimide and pest exterminating agent comprising the same as active ingredient |
| 06/24/2010 | WO2010071210A1 Chondrocyte-like cell, and method for producing same |
| 06/24/2010 | WO2010071164A1 Activated blood coagulation factor x (fxa) inhibitor |
| 06/24/2010 | WO2010071121A1 Method for producing diamine derivative |
| 06/24/2010 | WO2010071051A1 Melanin formation inhibitor and preparation for external application |
| 06/24/2010 | WO2010070910A1 1-heterodiene derivative and harmful organism control agent |
| 06/24/2010 | WO2010070705A1 Aqueous oral preparation of stable amlodipine |
| 06/24/2010 | WO2010070675A2 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof |
| 06/24/2010 | WO2010070672A2 A phytochemical composition and a process thereof |
| 06/24/2010 | WO2010070664A1 Curcuminoids and its metabolites for the application in ocular diseases |
| 06/24/2010 | WO2010070617A1 Inclusion complexes of alpha-cyclodextrin and sildenafil salt |
| 06/24/2010 | WO2010070615A1 Cysteine protease inhibitors |
| 06/24/2010 | WO2010070611A1 Atazanavir formulations |
| 06/24/2010 | WO2010070589A2 A novel dermaceutical cream made using sodium fusidate |
| 06/24/2010 | WO2010070523A1 Monocarbams |
| 06/24/2010 | WO2010070452A1 Fused imidazole carboxamides as trpv3 modulators |
| 06/24/2010 | WO2010070379A1 Rxr-ppargamma agonist/growth factor inhibitor combination therapy for inducing apoptosis and the treatment of cancer |
| 06/24/2010 | WO2010070365A1 1,3-heterocycles condensed with monoterpene skeleton, their use and pharmaceutical compositions comprising such compounds |
| 06/24/2010 | WO2010070343A1 1,3,4-oxadiazole derivatives and their uses to treat diabetes |
| 06/24/2010 | WO2010070292A1 A composition for use on skin and wound |
| 06/24/2010 | WO2010070238A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof |
| 06/24/2010 | WO2010070237A1 Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof |
| 06/24/2010 | WO2010070236A1 Formulation for the buccal transmucosal administration of setrons |
| 06/24/2010 | WO2010070210A1 Pharmaceutical composition containing an n-phenylpyrazole derivative, and use thereof for preparing a topical veterinary drug for flea control |
| 06/24/2010 | WO2010070207A1 Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells |
| 06/24/2010 | WO2010070183A1 Pharmaceutical composition comprising oleuropein for utilisation in angiogenesis and vasculogenesis induction |
| 06/24/2010 | WO2010070117A1 Treatment method by the administration of anti-her2 targeted active compounds to patients with early breast cancer and her2-negative primary tumor |
| 06/24/2010 | WO2010070093A1 Crystalline form c of tigecycline dihydrochloride and methods for its preparation |
| 06/24/2010 | WO2010070090A1 Solid composition containing the ingredient rasagiline |
| 06/24/2010 | WO2010070076A1 Alkanoic acid derivatives and their therapeutic use as hdac inhibitors |
| 06/24/2010 | WO2010070061A1 Compositions, kits and methods of a titration schedule for bifeprunox compounds |
| 06/24/2010 | WO2010070060A1 Bicyclic pyrazoles as protein kinase inhibitors |
| 06/24/2010 | WO2010070049A1 Cosmetic and pharmaceutical formulations of calixarene molecules |
| 06/24/2010 | WO2010070032A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
| 06/24/2010 | WO2010070023A2 Formulations |
| 06/24/2010 | WO2010070022A1 Novel compounds |
| 06/24/2010 | WO2010070021A1 Novel compounds |
| 06/24/2010 | WO2010070008A1 Substituted bicyclic imidazole derivatives as gamma secretase modulators |
| 06/24/2010 | WO2010069979A1 Pyran derivatives as ccr3 modulators |
| 06/24/2010 | WO2010069966A1 Substituted indazole derivatives active as kinase inhibitors |
| 06/24/2010 | WO2010069949A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis |
| 06/24/2010 | WO2010069915A1 Medical dietary composition for treating neurodegenerative diseases |
| 06/24/2010 | WO2010069882A1 Isoxazole derivatives for use as fungicides |
| 06/24/2010 | WO2010069859A1 Cyclohexanecarboxamide derivatives useful as inhibitors of cholesteryl ester transfer protein |
| 06/24/2010 | WO2010069850A1 Macrolactone derivatives, method for the production thereof and use thereof for the treatment of cancer |
| 06/24/2010 | WO2010069833A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation |
| 06/24/2010 | WO2010069795A2 Capecitabine rapidly disintegrating tablets |
| 06/24/2010 | WO2010069794A1 Thiadiazole-substituted arylamides |
| 06/24/2010 | WO2010069684A1 Compounds for treatment of duchenne muscular dystrophy |
| 06/24/2010 | WO2010069621A1 Treatment of vaginal atrophy in women with cardiovascular pathology risk |
| 06/24/2010 | WO2010069605A2 Oxidized cardiolipin as a novel pro-inflammatory factor |
| 06/24/2010 | WO2010069604A1 Treatment of diarrhoea |
| 06/24/2010 | WO2010069597A1 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases |
| 06/24/2010 | WO2010069595A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 06/24/2010 | WO2010069561A1 Cocrystals of tramadol and paracetamol |
| 06/24/2010 | WO2010069519A1 Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7 |
| 06/24/2010 | WO2010069507A1 Nicotine-containing product |
| 06/24/2010 | WO2010069504A1 (3-oxo)pyridin-4-ylurea derivatives as pde4 inhibitors |
| 06/24/2010 | WO2010069495A1 Atpenins |
| 06/24/2010 | WO2010069493A1 Improved combination of active agents comprising an antibiotic and a non-steroidal anti-inflammatory drug (nsaid) |
| 06/24/2010 | WO2010069441A1 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives |
| 06/24/2010 | WO2010069322A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 06/24/2010 | WO2010069150A1 Para-hydroxybenzene acrylic acid derivatives and uses thereof |
| 06/24/2010 | WO2010069147A1 Dihydropyrimidine derivatives, compositions thereof and their use |
| 06/24/2010 | WO2010069141A1 A controlled-released osmotic pump tablet with lubricating layer and the preparation thereof |
| 06/24/2010 | WO2010069140A1 Medicinal product of oryzanol and preparation method thereof |
| 06/24/2010 | WO2010069139A1 Pharmaceutical composition and preparation method thereof |
| 06/24/2010 | WO2010069138A1 Oryzanol composition and preparation method thereof |